Perwitasari O - Search Results

1

MicroRNA-555 has potent antiviral properties against poliovirus.

Shim BS, Wu W, Kyriakis CS, Bakre A, Jorquera PA, Perwitasari O, Tripp RA. Shim BS, et al. Among authors: perwitasari o. J Gen Virol. 2016 Mar;97(3):659-668. doi: 10.1099/jgv.0.000372. Epub 2015 Dec 18. J Gen Virol. 2016. PMID: 26683768

2

Targeting cell division cycle 25 homolog B to regulate influenza virus replication.

Perwitasari O, Torrecilhas AC, Yan X, Johnson S, White C, Tompkins SM, Tripp RA. Perwitasari O, et al. J Virol. 2013 Dec;87(24):13775-84. doi: 10.1128/JVI.01509-13. Epub 2013 Oct 9. J Virol. 2013. PMID: 24109234 Free PMC article.

3

MicroRNA Regulation of Human Genes Essential for Influenza A (H7N9) Replication.

Wolf S, Wu W, Jones C, Perwitasari O, Mahalingam S, Tripp RA. Wolf S, et al. Among authors: perwitasari o. PLoS One. 2016 May 11;11(5):e0155104. doi: 10.1371/journal.pone.0155104. eCollection 2016. PLoS One. 2016. PMID: 27166678 Free PMC article.

4

Targeting organic anion transporter 3 with probenecid as a novel anti-influenza a virus strategy.

Perwitasari O, Yan X, Johnson S, White C, Brooks P, Tompkins SM, Tripp RA. Perwitasari O, et al. Antimicrob Agents Chemother. 2013 Jan;57(1):475-83. doi: 10.1128/AAC.01532-12. Epub 2012 Nov 5. Antimicrob Agents Chemother. 2013. PMID: 23129053 Free PMC article.

5

siRNA Genome Screening Approaches to Therapeutic Drug Repositioning.

Perwitasari O, Bakre A, Tompkins SM, Tripp RA. Perwitasari O, et al. Pharmaceuticals (Basel). 2013 Jan 28;6(2):124-60. doi: 10.3390/ph6020124. Pharmaceuticals (Basel). 2013. PMID: 24275945 Free PMC article.

6

Verdinexor, a novel selective inhibitor of nuclear export, reduces influenza a virus replication in vitro and in vivo.

Perwitasari O, Johnson S, Yan X, Howerth E, Shacham S, Landesman Y, Baloglu E, McCauley D, Tamir S, Tompkins SM, Tripp RA. Perwitasari O, et al. J Virol. 2014 Sep 1;88(17):10228-43. doi: 10.1128/JVI.01774-14. Epub 2014 Jun 25. J Virol. 2014. PMID: 24965445 Free PMC article.

7

A pioneering countermeasure against measles virus.

Perwitasari O, Tripp RA. Perwitasari O, et al. Ann Transl Med. 2015 May;3(Suppl 1):S15. doi: 10.3978/j.issn.2305-5839.2015.02.29. Ann Transl Med. 2015. PMID: 26046060 Free PMC article. No abstract available.

8

Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.

Perwitasari O, Yan X, O'Donnell J, Johnson S, Tripp RA. Perwitasari O, et al. Assay Drug Dev Technol. 2015 Dec;13(10):638-49. doi: 10.1089/adt.2015.0003.drrr. Epub 2015 Jul 20. Assay Drug Dev Technol. 2015. PMID: 26192013 Free PMC article.

9

Antiviral Efficacy of Verdinexor In Vivo in Two Animal Models of Influenza A Virus Infection.

Perwitasari O, Johnson S, Yan X, Register E, Crabtree J, Gabbard J, Howerth E, Shacham S, Carlson R, Tamir S, Tripp RA. Perwitasari O, et al. PLoS One. 2016 Nov 28;11(11):e0167221. doi: 10.1371/journal.pone.0167221. eCollection 2016. PLoS One. 2016. PMID: 27893810 Free PMC article.

10

Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment.

Wolf S, Johnson S, Perwitasari O, Mahalingam S, Tripp RA. Wolf S, et al. Among authors: perwitasari o. Clin Transl Immunology. 2017 Mar 31;6(3):e135. doi: 10.1038/cti.2017.8. eCollection 2017 Mar. Clin Transl Immunology. 2017. PMID: 28435679 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters